Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Freedom Study: Myfortic in Kidney Transplant Patients

ClinicalTrials.gov ID: NCT00101738

Public ClinicalTrials.gov record NCT00101738. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 2:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Study to Investigate the Clinical Outcomes of Different Regimens of Myfortic® in De Novo Kidney Tx Pts Using Simulect® and Neoral® With or Without Steroids

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of the study is to evaluate that 3 immunosuppressant regimens will have comparable kidney function results in kidney transplant patients.

Study identification

NCT ID
NCT00101738
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
342 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2003 (Type not available)
Primary completion
May 2005 (Actual)
Completion
May 2005 (Actual)
Last update posted
Jan 31, 2011

2003 – 2005

United States locations

U.S. sites
9
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
UCSF Kidney Transplant Service San Francisco California 94143-0780 —
Livelink, Inc. Tampa Florida 33606 —
Loyola Medical Center Maywood Illinois 60153 —
Indiana U. Medical Center Indianapolis Indiana 46202 —
University of Michigan Health System Ann Arbor Michigan 48109 —
University Hospitals of Cleveland, Division of Nephrology Cleveland Ohio 44106 —
Ohio State University Medical Center Columbus Ohio 43210 —
Legacy Research & Technology Ctr. Portland Oregon 97232 —
U. of Wisconsin Hospital Clinics Madison Wisconsin 53792-7375 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 35 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00101738, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 31, 2011 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00101738 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →